Correction: Corrigendum: T-cell activation is an immune correlate of risk in BCG vaccinated infants
Nature Communications 7, Article number: 11290 (2016); Published: 12 April 2016; Updated: 6 May 2016. The original version of this Article contained an error in the spelling of the author Mark Hatherill, which was incorrectly given as Mark Hatheril. This has now been corrected in both the PDF and HT...
Main Authors: | Helen A. Fletcher, Margaret A. Snowden, Bernard Landry, Wasima Rida, Iman Satti, Stephanie A. Harris, Magali Matsumiya, Rachel Tanner, Matthew K. O’Shea, Veerabadran Dheenadhayalan, Leah Bogardus, Lisa Stockdale, Leanne Marsay, Agnieszka Chomka, Rachel Harrington-Kandt, Zita-Rose Manjaly-Thomas, Vivek Naranbhai, Elena Stylianou, Fatoumatta Darboe, Adam Penn-Nicholson, Elisa Nemes, Mark Hatherill, Gregory Hussey, Hassan Mahomed, Michele Tameris, J. Bruce McClain, Thomas G. Evans, Willem A. Hanekom, Thomas J. Scriba, Helen McShane |
---|---|
Format: | Article |
Language: | English |
Published: |
Nature Publishing Group
2016-05-01
|
Series: | Nature Communications |
Online Access: | https://doi.org/10.1038/ncomms11633 |
Similar Items
-
T-cell activation is an immune correlate of risk in BCG vaccinated infants
by: Helen A. Fletcher, et al.
Published: (2016-04-01) -
Host blood transcriptomic biomarkers of tuberculosis disease in people living with HIV: a systematic review protocol
by: Mary Shelton, et al.
Published: (2021-08-01) -
The candidate TB vaccine, MVA85A, induces highly durable Th1 responses.
by: Michele Tameris, et al.
Published: (2014-01-01) -
Evaluation of Xpert® MTB/RIF Assay in Induced Sputum and Gastric Lavage Samples from Young Children with Suspected Tuberculosis from the MVA85A TB Vaccine Trial.
by: Erick Wekesa Bunyasi, et al.
Published: (2015-01-01) -
Transcriptomic signatures of recurrent tuberculosis disease and treatment response in HIV-infected individuals
by: Darboe, Fatoumatta
Published: (2019)